Announced Fri, 1 May · 12:26 IST

Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Audited Financial ....

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+7.2%1-day move
₹576.90
prior close
₹579.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+2.0+2.4+4.3+7.2+7.7+5.6+5.0+8.1+5.2+14.1+10.8+13.0
Up moveDown movePending
AI summary

HealthCare Global Enterprises Limited (HCG), a specialty cancer care hospital chain, has informed exchanges that its Board meeting is scheduled for May 19, 2026 to consider and approve the Audited Financial Results for Q4 and FY 2025-26. The trading window has been closed for all Designated Persons from April 01, 2026 and will remain closed until 48 hours after the results are declared. This is a routine pre-result intimation filed under SEBI Listing Regulation 29. No specific financial figures or agenda details beyond the audited results approval are disclosed in this notice.

Likely market impact

This is a standard regulatory intimation with no new material information; the actual impact on the stock will depend on the numbers and performance disclosed in the audited results when declared.